To evaluate outcomes of fornix deepening with retractor recession and repositioning for conjunctivochalasis (CCh) on improvement of conjunctival folds and ocular surface symptoms, particularly epiphora.
Methods
Retrospective, single-centre, observational case series of patients with refractory CCh who underwent fornix deepening and retractor recession. CCh was graded using the Hoh classification (grades 0 to 3 depending on the number and height of folds). Epiphora, reflex tearing, and dry eye symptoms were assessed using the validated 'TEAR' score pre- and post-CCh correction.
Results
18 eyes of 11 patients with CCh (average age 68, range 46–82 years) were treated with fornix deepening and retractor recession. All had shallow fornices pre-operatively with a mean CCh grade of 1.7 (typically lower than the tear meniscus). Locations of the folds were variable: diffuse/middle (n = 10), nasal (n = 4), and temporal (n = 4). At 15-month mean follow-up, conjunctival redundancy was absent in 17 of 18 eyes postoperatively, resulting in a restored tear meniscus and reservoir. 91% saw a reduction in tearing frequency (T), with 73% gaining ≥ 2-point improvement. Improvements in clinical effects (E) and activity limitation (A) were seen in 82% and 91% of patients, respectively, with 36% and 64% gaining ≥ 2-point improvement. R scores (related to reflex tearing) improved in 73%, with 64% seeing ≥ 2-point gains. (P < 0.05 for all).
Conclusion
Restoration of the tear reservoir by inferior fornix deepening with retractor recession and repositioning can result in improvement of CCh and epiphora.
ChengAMYinHYChenR, et al.Restoration of fornix tear reservoir in conjunctivochalasis with Fornix reconstruction. Cornea2016; 35: 736–740. 2016/02/19. DOI: https://doi.org/10.1097/ico.0000000000000784.
3.
MishimaSGassetAKlyce Jr.SD, et al.Determination of tear volume and tear flow. Invest Ophthalmol1966; 5: 264–276. 1966/06/01.
MellerDTsengSC. Conjunctivochalasis: literature review and possible pathophysiology. Surv Ophthalmol1998; 43: 225–232. 1998/12/23. DOI: https://doi.org/10.1016/s0039-6257(98)00037-x.
6.
HuangYShehaHTsengSC. Conjunctivochalasis interferes with tear flow from fornix to tear meniscus. Ophthalmology2013; 120: 1681–1687. 2013/04/16. DOI: https://doi.org/10.1016/j.ophtha.2013.01.007.
7.
Di PascualeMAEspanaEMKawakitaT, et al.Clinical characteristics of conjunctivochalasis with or without aqueous tear deficiency. Br J Ophthalmol2004; 88: 388–392. 2004/02/24. DOI: https://doi.org/10.1136/bjo.2003.025460.
8.
GanJ-YLiQ-SZhangZ-Y, et al.The role of elastic fibers in pathogenesis of conjunctivochalasis. Int J Ophthalmol2017; 10: 1465–1473. DOI: https://doi.org/10.18240/ijo.2017.09.21
BalciO. Clinical characteristics of patients with conjunctivochalasis. Clin Ophthalmol2014; 8: 1655–1660. DOI: https://doi.org/10.2147/OPTH.S61851
11.
HöhHSchirraFKieneckerC, et al.[Lid-parallel conjunctival folds are a sure diagnostic sign of dry eye]. Ophthalmologe1995; 92: 802–808. 1995/12/01.
12.
SchulzCBMalhotraR. The 'tears’ score: a tool for grading and monitoring epiphora. Eur J Ophthalmol2022; 32: 2108–2115. 2022/06/01. DOI: https://doi.org/10.1177/11206721221104550.
13.
OzcuraFAydinSHelvaciMR. Ocular surface disease index for the diagnosis of dry eye syndrome. Ocul Immunol Inflamm2007; 15: 389–393. 2007/11/01. DOI: https://doi.org/10.1080/09273940701486803.
14.
SchiffmanRMChristiansonMDJacobsenG, et al.Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol2000; 118: 615–621. 2000/05/18. DOI: https://doi.org/10.1001/archopht.118.5.615.
15.
PrabhasawatPTsengSC. Frequent association of delayed tear clearance in ocular irritation. Br J Ophthalmol1998; 82: 666–675. 1998/11/03. DOI: https://doi.org/10.1136/bjo.82.6.666.
16.
LiuD. Conjunctivochalasis. A cause of tearing and its management. Ophthalmic Plast Reconstr Surg1986; 2: 25–28. 1986/01/01.
17.
MellerDLiDQTsengSC. Regulation of collagenase, stromelysin, and gelatinase B in human conjunctival and conjunctivochalasis fibroblasts by interleukin-1beta and tumor necrosis factor-alpha. Invest Ophthalmol Vis Sci2000; 41: 2922–2929. 2000/09/01.
18.
WangYDogruMMatsumotoY, et al.The impact of nasal conjunctivochalasis on tear functions and ocular surface findings. Am J Ophthalmol2007; 144: 930–937.e1. 2007/10/06. DOI: https://doi.org/10.1016/j.ajo.2007.07.037.
19.
LiDQMellerDLiuY, et al.Overexpression of MMP-1 and MMP-3 by cultured conjunctivochalasis fibroblasts. Invest Ophthalmol Vis Sci2000; 41: 404–410. 2000/02/12.
20.
AceraASuárezTRodríguez-AgirretxeI, et al.Changes in tear protein profile in patients with conjunctivochalasis. Cornea2011; 30: 42–49. 2010/09/24. DOI: https://doi.org/10.1097/ICO.0b013e3181dea7d7.
21.
ChhadvaPAlexanderAMcClellanAL, et al.The impact of conjunctivochalasis on dry eye symptoms and signs. Invest Ophthalmol Vis Sci2015; 56: 2867–2871. 2015/05/30. DOI: https://doi.org/10.1167/iovs.14-16337.
22.
DossLRDossELDossRP. Paste-pinch-cut conjunctivoplasty: subconjunctival fibrin sealant injection in the repair of conjunctivochalasis. Cornea2012; 31: 959–962. 2012/03/13. DOI: https://doi.org/10.1097/ICO.0b013e3182400100.
23.
QiuWZhangMXuT, et al.Evaluation of the effects of conjunctivochalasis excision on tear stability and contrast sensitivity. Sci Rep2016; 6: 37570. 2016/11/29. DOI: https://doi.org/10.1038/srep37570.
24.
ÇağlayanMKösekahyaPGürdalC, et al.Comparison of electrocoagulation and conventional medical drops for treatment of conjunctivochalasis: short-term results. Turk J Ophthalmol2018; 48: 61–65. 2018/05/15. DOI: https://doi.org/10.4274/tjo.35002.
25.
HaefligerIOVysniauskieneIFigueiredoAR, et al.Superficial conjunctiva cauterization to reduce moderate conjunctivochalasis. Klin Monbl Augenheilkd2007; 224: 237–239. 2007/04/27. DOI: https://doi.org/10.1055/s-2007-962928.
26.
KashimaTAkiyamaHMiuraF, et al.Improved subjective symptoms of conjunctivochalasis using bipolar diathermy method for conjunctival shrinkage. Clin Ophthalmol2011; 5: 1391–1396. 2011/10/29. DOI: https://doi.org/10.2147/opth.S24475.
27.
ArenasEMuñozD. A new surgical approach for the treatment of conjunctivochalasis: reduction of the conjunctival fold with bipolar electrocautery forceps. ScientificWorldJournal2016; 2016: 6589751. 2016/05/21. DOI: https://doi.org/10.1155/2016/6589751.
28.
SantiagoEYangYConlonR, et al.Surgical techniques for the treatment of conjunctivochalasis: paste-pinch-cut conjunctivoplasty versus thermal cautery conjunctivoplasty. Can J Ophthalmol2017; 52: 308–312. 2017/06/04. DOI: https://doi.org/10.1016/j.jcjo.2016.11.003.
NakasatoHUemotoRMeguroA, et al.Treatment of symptomatic inferior conjunctivochalasis by ligation. Acta Ophthalmol (Copenh)2014; 92: e411–e412. DOI: https://doi.org/10.1111/aos.12349
31.
ShinKHHwangJHKwonJW. New approach for conjunctivochalasis with argon laser photocoagulation. Can J Ophthalmol2012; 47: 380–382. 2012/08/14. DOI: https://doi.org/10.1016/j.jcjo.2012.03.035.
HanJLeeSHChoiCY, et al.Treatment outcomes of modified argon laser photocoagulation for conjunctivochalasis. Medicine (Baltimore2023; 102: e32633. 2023/01/14. DOI: https://doi.org/10.1097/md.0000000000032633.
34.
JiYWSeongHLeeS, et al.The correction of conjunctivochalasis using high-frequency radiowave electrosurgery improves dry eye disease. Sci Rep2021; 11: 2551. DOI: https://doi.org/10.1038/s41598-021-82088-5
35.
YoumDJKimJMChoiCY. Simple surgical approach with high-frequency radio-wave electrosurgery for conjunctivochalasis. Ophthalmology2010; 117: 2129–2133. 2010/06/24. DOI: https://doi.org/10.1016/j.ophtha.2010.02.023.
36.
KheirkhahACasasVBlancoG, et al.Amniotic membrane transplantation with fibrin glue for conjunctivochalasis. Am J Ophthalmol2007; 144: 311–313. 2007/07/31. DOI: https://doi.org/10.1016/j.ajo.2007.03.044.
37.
GeorgiadisNSTerzidouCD. Epiphora caused by conjunctivochalasis: treatment with transplantation of preserved human amniotic membrane. Cornea2001; 20: 619–621. 2001/07/27. DOI: https://doi.org/10.1097/00003226-200108000-00012.
38.
MaskinSL. Effect of ocular surface reconstruction by using amniotic membrane transplant for symptomatic conjunctivochalasis on fluorescein clearance test results. Cornea2008; 27: 644–649. 2008/06/27. DOI: https://doi.org/10.1097/QAI.0b013e31815e723f.
39.
MellerDMaskinSLPiresRT, et al.Amniotic membrane transplantation for symptomatic conjunctivochalasis refractory to medical treatments. Cornea2000; 19: 796–803. 2000/11/30. DOI: https://doi.org/10.1097/00003226-200011000-00008.
40.
UcarF. Alternative approach for the treatment of conjunctivochalasis: plasma-based conjunctivoplasty. Cornea2023; 43: 201–206. DOI: https://doi.org/10.1097/ico.0000000000003276.
41.
SerranoFMoraLM. Conjunctivochalasis: a surgical technique. Ophthalmic Surg1989; 20: 883–884. 1989/12/01.
PetrisCKHoldsJB. Medial conjunctival resection for tearing associated with conjunctivochalasis. Ophthalmic Plast Reconstr Surg2013; 29: 304–307. 2013/06/22. DOI: https://doi.org/10.1097/IOP.0b013e3182831dd3.
44.
ChengAMSMeadOGTigheS, et al.Fornix deepening reconstruction in conjunctivochalasis surgery. Taiwan J Ophthalmol2023; 13: 49–54. 2023/05/30. DOI: https://doi.org/10.4103/tjo.tjo_28_22.
45.
MalhotraCJainAK. Human amniotic membrane transplantation: different modalities of its use in ophthalmology. World J Transplant2014; 4: 111–121. 2014/07/18. DOI: https://doi.org/10.5500/wjt.v4.i2.111.
46.
PotvinRMakariSRapuanoCJ. Tear film osmolarity and dry eye disease: a review of the literature. Clin Ophthalmol2015; 9: 2039–2047. 2015/11/21. DOI: https://doi.org/10.2147/opth.S95242.
